CSL - Loan Capital


CSL reported $10.42B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
aTyr Pharma USD 1.72M 10.79M Mar/2026
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Immunic USD 0 0 Jun/2024
Minerva Neurosciences USD 0 86.58M Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
TherapeuticsMD USD 0 0 Mar/2022